Neuren Pharmaceuticals Ltd (NEU.AX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 20,824 | 24,336 | 10,233 | 14,949 | 2,818 |
| Receivables | 963 | 1,618 | 130 | 105 | 326 |
| TOTAL | $21,787 | $25,997 | $10,482 | $15,140 | $3,429 |
| Non-Current Assets | |||||
| PPE Net | 29 | 23 | 25 | 5 | 17 |
| Intangibles | 290 | 393 | 3,189 | 3,538 | 3,888 |
| TOTAL | $319 | $416 | $3,215 | $3,543 | $3,906 |
| Total Assets | $22,106 | $26,413 | $13,697 | $18,683 | $7,334 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | 0 | 454 |
| Accounts payable and accrued liabilities | 2,755 | 1,849 | 2,122 | 1,677 | 1,714 |
| Other current liabilities | N/A | N/A | 6 | 7 | 9 |
| TOTAL | $3,028 | $2,058 | $2,531 | $2,146 | $2,559 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 221 | 204 | 157 | 45 | 47 |
| TOTAL | $0 | $0 | $13 | $0 | $7 |
| Total Liabilities | $3,028 | $2,058 | $2,544 | $2,146 | $2,566 |
| Shareholders' Equity | |||||
| Common Shares | 104,363 | 101,997 | 64,177 | 61,144 | 52,280 |
| Retained earnings | -84,148 | -87,291 | -65,571 | -58,007 | -53,251 |
| Other shareholders' equity | -916 | 9,854 | 7,878 | 6,256 | 4,494 |
| TOTAL | $19,299 | $24,559 | $6,484 | $9,394 | $3,523 |
| Total Liabilities And Equity | $22,327 | $26,617 | $9,028 | $11,540 | $6,089 |